Ashok K Srivastava

Title: Ashok K Srivastava: Innovator in Japanese Encephalitis Vaccine Development

Introduction

Ashok K Srivastava is a notable inventor based in Washington, DC. He has made significant contributions to the field of virology, particularly in the development of vaccines. His work focuses on the Japanese encephalitis virus, which poses a serious health risk in many regions.

Latest Patents

Ashok K Srivastava holds a patent for an attenuated Japanese encephalitis virus adapted to Vero cells. This innovation is crucial as it provides a foundation for a Japanese encephalitis vaccine. The patent details the process of adapting the virus through passages on Vero cells, which enhances its efficacy as a vaccine.

Career Highlights

Throughout his career, Ashok has demonstrated a commitment to advancing medical science. His research has led to breakthroughs that can potentially save lives and improve public health. His patent is a testament to his innovative approach and dedication to addressing infectious diseases.

Collaborations

Ashok has worked alongside esteemed colleagues such as Hyun Su Kim and Bruce L Innis. Their collaborative efforts have contributed to the success of his research and the development of effective vaccines.

Conclusion

Ashok K Srivastava's work in developing a Japanese encephalitis vaccine highlights his role as a key innovator in the field of virology. His contributions are vital for public health and demonstrate the importance of continued research in vaccine development.